Fagron was recently selected by American Pharmaceutical Ingredients to directly service API’s customers with continued supply of active ingredients for compounding.
AMERICAN PHARMACEUTICAL INGREDIENTS TO SHIFT FOCUS TO SUPPLYING US FDA APPROVED FINISHED DOSAGE DRUGS |
[01-February-2018] |
ST. PAUL, Minn., Feb. 1, 2018 /PRNewswire/ -- Fagron was recently selected by American Pharmaceutical Ingredients (API) to directly service API’s customers with continued supply of active ingredients for compounding. With API’s recent business decision to solely focus on the distribution of US FDA-approved finished dosage products, API’s customers now have access to Fagron’s extensive portfolio of bulk pharmaceutical ingredients, excipients, innovative creams, lotions, syrups, and suspending vehicles. “We conducted extensive research of the US-pharmaceutical market before identifying Fagron as a suitable option for our customers,” states API Founder, Karl Jebailey, “Although API will no longer distribute bulk active ingredients, we wanted to ensure our customers receive the best turn-key solution for quality supply chain of compounding items.” Fagron, Inc., a Fagron global company, sets the standard in premium quality. Based in St. Paul, MN, it is a US FDA and DEA-registered pharmaceutical manufacturer that strictly adheres to current Good Manufacturing Practices (cGMP). All batches are tested for identity, strength, quality, purity and compliance with relevant USP or other monographs in Fagron’s in-house analytical laboratory. “We are thrilled with our collaboration with API,” stated Ronaldo Steentjes, President Fagron, Inc., “As the compounding industry continues to evolve, we are proud to step in to help ensure customers continue to receive the high-quality pharmaceutical ingredients they expect and deserve.” About Fagron, Inc. About Fagron North America About American Pharmaceutical Ingredients
View original content with multimedia:http://www.prnewswire.com/news-releases/fagron-inc-extends-pharmaceutical-ingredient-supply-chain-to-american-pharmaceutical-ingredients-customers-300591687.html SOURCE Fagron, Inc. |